Literature DB >> 8621433

Jun kinases are rapidly activated by cholecystokinin in rat pancreas both in vitro and in vivo.

A Dabrowski1, T Grady, C D Logsdon, J A Williams.   

Abstract

Stimulation of pancreatic acini from male Sprague-Dawley rats by both cholecystokinin (CCK)-8 and anisomycin caused an increase in p46jnk and p55jnk activities. Both forms of c-Jun amino-terminal kinase (JNK) were slightly activated at 5 min, reached a maximum at 30 min, and remained significantly increased at 60 min of CCK stimulation. By contrast, p42mapkwas activated fully by 5 min. In pancreatic acini stimulated with different concentrations of CCK for 30 min, the minimal and maximal JNK responses were observed at 30 pm and 100 nM CCK, respectively; p42mapk activation was, as previously reported, much more sensitive, with maximal activation by 1 nm CCK. Carbachol and bombesin also stimulated JNK activity, while vasoactive intestinal peptide did not. Neither activating protein kinase C nor increasing intracellular Ca2+ significantly activated JNK. In in vivo experiments, rats were infused intravenously for 5 and 15 min with a secretory (0.1 microg/kg/h) or supramaximal (10 microg/kg/h) dose of the CCK analog caerulein (CER). Secretory doses of CER induced a 4-fold increase of both forms of JNK in pancreatic tissue at 5 and 15 min, while at the same time points, supramaximal stimulation with CER caused 4- and 27-fold increases, respectively, of these kinase activities. The secretory dose of CER slightly increased the activities of both forms of mitogen-activated protein kinase, while the supramaximal dose induced a 10-fold increase of p42mapk at 5 min. In conclusion, JNKs and mitogen-activated protein kinases are rapidly activated in rat pancreatic acini stimulated with CCK as well as in pancreatic tissue during in vivo stimulation with CER. The large response to supramaximal CER stimulation may be of importance in the early pathogenesis of acute pancreatitis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8621433     DOI: 10.1074/jbc.271.10.5686

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Nicotine-induced proliferation of isolated rat pancreatic acinar cells: effect on cell signalling and function.

Authors:  P Chowdhury; C Bose; K B Udupa
Journal:  Cell Prolif       Date:  2007-02       Impact factor: 6.831

2.  Differential regulation of extracellular signal-regulated protein kinase 1 and Jun N-terminal kinase 1 by Ca2+ and protein kinase C in endothelin-stimulated Rat-1 cells.

Authors:  K Cadwallader; J Beltman; F McCormick; S Cook
Journal:  Biochem J       Date:  1997-02-01       Impact factor: 3.857

3.  Cholecystokinin octapeptide inhibits Ca2+-dependent amylase secretion from permeabilized pancreatic acini by blocking the MgATP-dependent priming of exocytosis.

Authors:  P J Padfield; N Panesar
Journal:  Biochem J       Date:  1998-02-15       Impact factor: 3.857

Review 4.  G Protein-Coupled Receptor Kinases in the Inflammatory Response and Signaling.

Authors:  Michael D Steury; Laura R McCabe; Narayanan Parameswaran
Journal:  Adv Immunol       Date:  2017-06-10       Impact factor: 3.543

5.  Mechanisms for nicotine in the development and progression of gastrointestinal cancers.

Authors:  Kendal Jensen; Syeda Afroze; Md Kamruzzaman Munshi; Micheleine Guerrier; Shannon S Glaser
Journal:  Transl Gastrointest Cancer       Date:  2012-04

6.  Stress kinase inhibition modulates acute experimental pancreatitis.

Authors:  F Fleischer; R Dabew; B Göke; A C Wagner
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

7.  c-Jun/AP-1 is required for CCK-induced pancreatic acinar cell dedifferentiation and DNA synthesis in vitro.

Authors:  Lili Guo; Maria Dolors Sans; Yanan Hou; Stephen A Ernst; John A Williams
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-03-29       Impact factor: 4.052

8.  Bombesin stimulates cholecystokinin secretion through mitogen-activated protein-kinase-dependent and -independent mechanisms in the enteroendocrine STC-1 cell line.

Authors:  E Némoz-Gaillard; M Cordier-Bussat; C Filloux; J C Cuber; E Van Obberghen; J A Chayvialle; J Abello
Journal:  Biochem J       Date:  1998-04-01       Impact factor: 3.857

Review 9.  Therapeutic potential for novel drugs targeting the type 1 cholecystokinin receptor.

Authors:  Erin E Cawston; Laurence J Miller
Journal:  Br J Pharmacol       Date:  2009-11-18       Impact factor: 8.739

10.  ERK activation is required for CCK-mediated pancreatic adaptive growth in mice.

Authors:  Bryan J Holtz; Kevin B Lodewyk; Judith S Sebolt-Leopold; Stephen A Ernst; John A Williams
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-08-07       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.